MANGANESE CHLORIDE IN PLASTIC CONTAINER
Details
- Status
- Prescription
- First Approved
- 1986-06-26
- Routes
- INJECTION
- Dosage Forms
- INJECTABLE
MANGANESE CHLORIDE IN PLASTIC CONTAINER Approval History
What MANGANESE CHLORIDE IN PLASTIC CONTAINER Treats
1 indicationsMANGANESE CHLORIDE IN PLASTIC CONTAINER is approved for 1 conditions since its original approval in 1986. These indications span multiple therapeutic areas including oncology, immunology, and more.
- Manganese Deficiency
Drugs Similar to MANGANESE CHLORIDE IN PLASTIC CONTAINER
FDA-approved drugs for similar conditions. Compare mechanisms and indications to understand treatment alternatives.
Active Pipeline
Ongoing clinical trials by development phase
Key Completed Trials
Completed studies with published results, ranked by significance
Trial Timeline
Full development history with FDA approval milestones
Understanding FDA Approval Types
| Count | Type | What it means |
|---|---|---|
| - | ORIG | Original approval - drug first enters market |
| - | SUPPL - Efficacy | New indication (new disease/condition approved) |
| - | SUPPL - Labeling | Label text changes (warnings, dosing updates) |
| - | SUPPL - Manufacturing | Production changes (new facility) |
| - | SUPPL - Chemistry | Formulation changes (new dosage strength) |
Green lines in the timeline show ORIG and Efficacy approvals - the clinically meaningful milestones.
MANGANESE CHLORIDE IN PLASTIC CONTAINER FDA Label Details
ProIndications & Usage
FDA Label (PDF)Manganese 0.1 mg/mL (Manganese Chloride Injection, USP) is indicated for use in adult patients as a supplement to intravenous solutions given for TPN. Administration helps to maintain manganese serum levels and to prevent depletion of endogenous stores and subsequent deficiency symptoms.
Want competitive intelligence?
See who's developing similar drugs and track their progress
Data Sources
Data sourced from official FDA and NIH databases. Click links to verify on original sources.